Cargando…
Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients
BACKGROUND: By end December of 2021, COVID-19 has infected around 276 million individuals and caused over 5 million deaths worldwide. Infection results in dysregulated systemic inflammation, multi-organ dysfunction, and critical illness. Cells of the central nervous system are also affected, trigger...
Ejemplares similares
-
HIF1A (rs11549465) and AKNA (rs10817595) Gene Polymorphisms Are Associated with Primary Sjögren's Syndrome
por: Hernández-Molina, Gabriela, et al.
Publicado: (2017) -
Opinión de Padres de Familia respecto a la Orientación sobre Prevención en el Consumo de Drogas que Reciben Sus Hijos /
por: Martínez Hernández, Gabriela
Publicado: (2008) -
Burnout Syndrome in a Military Tertiary Hospital Staff during the COVID-19 Contingency
por: Martínez-Cuazitl, Adriana, et al.
Publicado: (2022) -
Effect of Transforming Growth Factor-β upon Taenia solium and Taenia crassiceps Cysticerci
por: Adalid-Peralta, Laura, et al.
Publicado: (2017) -
Formación emprendedora en alumnos del área económico-administrativa, complejo regional nororiental BUAP
por: Salazar Arriaga, José Juan, et al.
Publicado: (2021)